Get Free Essays

ALZHEIMER'S DISEASE.   Term Paper ID:21498 Click to get this paper

Essay Subject: Causes, effects, pathologic process, research, types, immune system, aluminum, treatment alternatives focusing on acetylcholinesterase inhibitors.... More...

21 Pages / 4725 Words 31 sources, 56 Citations, OTHER Format $84.00 Return to List of Papers

Paper Abstract: Causes, effects, pathologic process, research, types, immune system, aluminum, treatment alternatives focusing on acetylcholinesterase inhibitors. Paper Introduction: Alzheimer's Disease/Senile Dementia of the Alzheimer Type: The Role of Acetylcholinesterase Inhibitors As the United States' population grows older, the chronic degenerative diseases of the elderly have become increasingly important. One condition that has received considerable attention is Alzheimer's disease, otherwise known as Senile Dementia of the Alzheimer Type (AD/SDAT). In recent years, researchers have begun to begun to elucidate the biochemical and physiological mechanisms which characterize this disorder. Moreover, despite the brain's inherent complexity and inaccessibility, several promising therapeutic modalities have emerged. Of these different agents, perhaps the acetylcholinesterase inhibitors exhibit the most potential. At the turn of the century, the average life expectancy in Text of the Paper: The entire text of the paper is shown below. However, the text is somewhat scrambled. We want to give you as much information as we possibly can about our papers and essays, but we cannot give them away for free. In the text below you will find that while disordered, many of the phrases are essentially intact. From this text you will be able to get a solid sense of the writing style, the concepts addressed, and the sources used in the research paper. that has received considerable attention Moreover despite the brain's inherent complexity andinaccessibility several promising the life expectancy for newborns international attention on the mental of people over the age of increase According to Alzheimer's Association President Edward Truschke Alzheimer's disease in health care resources throughout experts believe that AD SDAT willeventually become it wasn't until about the early th century that in Alois Alzheimer was able to demonstrateneuritic plaques and fact it wasn't until industrialization beganto alter population regard to dementia etiology Some believed it to studies Eventually in the s a major health problem As the years AD SDAT In this effort produced international cooperationand support to conquer is or years less thanaverage patients pathologic processes in Alzheimer's are functioning As such processes continue be difficult to detect They usually involve subtle changes to others Eventually patients can experience a progressive and simultaneous It has beenhypothesized that this may involve thedifferent capacities of of an appropriate history by excluding all othercauses generally made at autopsy The pathologic findingstypically include paired AD SDAT are primarily concentrated inthe gray matter regions of of a kDA glycoprotein amyloid peptide precursor As peptidedeposits accumulate they arrange into the fibrils areactually formed by microglia and pericytes It consists of five or primary degeneration of both theolfactory bulb and the of high-resolution computed tomography CT in the twodifferent subtypes Alzheimer's disease type I or classical Alzheimer'sis characterized both the temporal and parietal lobes For the In addition they may sufferfrom confusion vascular factors and tomography PET however may be employed in the analysis of the disease and persist Additionally theymay SDAT patientswith symptoms consisting predominantly of either aphasia or visuospatialdeficit patientswith primarily memory loss were observed to have hypotheses have been proposed Obviously there is abundant evidence Some of these apparent metabolic deficits however could alsoresult from demonstratedmembrane structural changes in both Alzheimer's and normal senescence has beenassociated with amyloid deposits under couldinitiate the formation of neurofibrillary tangles SDAT etiology is not yet known may lead to abuildup of amyloid precursor alsopossible that instead of being pathogenic plaques are cytoplasm represents a nonspecific response Ishii and Haga both observed IgG in senile plaques vigorously express theMHC class II surface glycoprotein HLA-DR The both T-helperinducer and T-cytotoxic suppressor cells immune responses couldalso result from some apparentplausibility of such hypotheses though they still lack convincing unlimited The metal may occur most predominantly in the neuritic plaques neurofibrillary tangles aluminum forms complexes with amino acidssuch as form stable linkages with either phosphoric groups Neuronal death and dementia might then occur as aconsequence of events may also occur in to aluminum it is not yetknown whether lesser the pathological hallmark of Alzheimer's deficit in Alzheimer's became widely thought to reflect a loss synthesis with the severity of patients'dementia Other experimental evidence AD SDAT are particularlyrelevant because somatostatinergic and glutamatergic as well asother neuropeptinergic it provides researchers with a potentially effectiveapproach to activities of daily living quality of life Theproblem theloss of target neurons projecting neurons and symptoms Ideally treatment should either fetal neural transplantationholds any promise for neuropeptide Y all seem to be to achieve therapeutic levels of the neuropeptides However many questionsregarding neurotrophic factor's usefulness in AD SDAT the nootropics andmiscellaneous agents that act Parkinson's The dopaminedeficit observed in Parkinson's disease In addition muscarinic cholineric agonistshave been applied to mimic the groups the acetylcholinesterase inhibitors show the greatestpromise Over metabolic inactivation of acetylcholine within seen early in the course in double-blind randomized cross-over clinical trials their Some of themore common drugs include tetrahydroaminoacridine THA and physostigmine Less well known AChE inhibitors on the central nervoussystem In control cortical tissue it structural similarityto aminopyridine Moreover like aminopyridine THA blocks potassiumchannels muscarinic receptorantagonists Although trials involving another well-known AChE inhibitor physostigmine has also beenused for several effect seems to be greatest when given to be inconsistent Moreover like methylcarbamic group Such substitutions mayinclude carbon atoms long alkylcarbamic it exert anequivalent AChE inhibitory effect at much addition MTF has also been shown to be quiteeffective of alkaloid drugs were isolated byChinese pharmacologists at the Shanghai may be themost potent Furthermore both drugs have fewer when an inhibitor moleculephysically or chemically blocks normalsubstrates These active-site-directed irreversible inhibitors also knownas result ofthese inhibitors' high reactivity require some type of chemicalactivation by the target molecule molecular kamikazes with the targeted enzymescatalyzing their own inactivation Obviously It is known for example that the AChE acetylcholine receptors The two compoundsare therefore said to e N CH Itforms a stereochemical fit with inhibits AChE throughits interaction with the physostigmine'sacyl methyl carbamoyl transfer inhibition In addition recent research has indicated anexoethylidene moiety and pyridone heteroatoms interact with AChE activesite amino and the brain's extracellular fluid endothelial cells or complex tight junction cells This gives the endothelium an ability to actively exclude BBB serve toregulate the composition of the interstitial fluid overcome the BBB For example peptidelipidization involves small peptide fragments be extreme A second approach to theBBB involves Scientists are only just beginning led to various treatments for research will be needed before a drug or a tyrosine in the binding of Huperzine A to the active Hopkins University Press pp Collins J O Mechanism of Alzheimer's disease Arguments for a neurotransmitter-aluminum dementia In Emery V O Oxman T K Wisniewski H M Winblad B eds Alzheimer's imaging of Alzheimer's disease Clinics in Geriatric Medicine May The blood-brain barrier Cellular and molecular biology New disorders New York NY Alan R Liss Inc pp NY Alan R Liss Inc pp Kirshner H S and nosology Baltimore Md The Johns Hopkins University Press and related disorders New York NY Alan R diagnosis and nosology Baltimore Md The Johns Iqbal K Wisniewski H M V O Oxman T E eds Dementia Presentations for dementia In Emery V O Oxman T E deterioration or clinical sub-types Journal of Clinical Epidemiology December Ross University Press pp Sage M R Turski P A Levin Book Company pp Santucci A C Haroutunian V Tsuboyama G disorders New York NY Alan R of a series of N-t-alkylpyridinium compounds Journal Wisniewski H M Milestones in the history of Alzheimer J Bobinski M Alzheimer dementia neuropathology In population grows older the chronicdegenerative diseases of the elderly have In recent years researchers have begun to begun century the average lifeexpectancy in the This demographic trend both in persons at riskfor a dementing illness increases millionpeople have the most common dementing illness Alzheimer's than even we thought It has been calculatedthat an average productivity That makesAlzheimer's the nation's third most expensive fact the diseasewas familiar to the method major advances were being made in bothmicroscopic and staining descriptions however many years passed before s to the s a researchers focused on theultrastructural and biochemical characteristics of the as those which occurred in senile dementia This realizationmade Secretary of the United States Departmentof Health and Human of AD and Other Dementias Currently even the fourth or fifth most common cause of death healthier counterparts Hence AD SDAT may Hence many younger people could bedeveloping neurophysiological signs interferes withpatients' ability to present themselves to the world in housecleaning orauto maintenance to changes in the loss of language abilities Overall though AD SDAT specificcortical areas whose relative weakness is genetically determined A clinical research For the most part onset as well as the rate and character of thedeterioration granulovacuoloar degeneration amyloid angiopathy loss of particular type of amyloid Thesedeposits form early to servesome kind of receptor function Processing at its C-terminus some authors believe that neuritic lesions These include the classical primitive and diffuseplaque formations Of deposits are ultimately toxic to neurons the gray matter the white-matter hyaline arteriolosclerosis in the periventricular whitematter With the discovery of vascular factors normal blood-brain barrier function and a low of general cognitive symptoms including memory disturbances These patients often present there is no laboratory diagnostic test available sensory and motorneocortical regions in living AD SDAT also present focally in either hemisphere Foster et lefthemisphere hypometabolism whereas the patients with well characterized the exact etiological mechanisms responsible include the following diminished glucose utilization reduced pyruvate dehydrogenase could result from abnormal synthesis of membranephospholipids another etiological mechanism for AD SDAT involves abnormalproteins antichymotrypsin creates a stable complex gene forone of the amyloid precursor proteins form of AD SDAT Some withthe presence of a proteoglycan receptor-type site and possible proteaseinhibition that progressive proteinalterations and the AD SDAT one may be the immune system Lastly the disease has alsobeen associated with the activation of therefore be partially responsible for the known though whether or not the response is the blood-brain barrierappear to undergo alteration This may make As the thirdmost abundant element in the earth's crust have been found inthe brains of AD SDAT patients on however whether these accumulations are a cause contributor or a and simple diffusion could then provide accumulation of three-dimensional protidic edifices such is evidence that in addition toAlzheimer's far however only two cases of dementia have been reported the fact that the observedstructural changes and cell death principal source of acetylcholine Itsdegeneration results in levels were decreased in the temporal cortex and hippocampus of CAT were also observed in otherneuroanatomic regions The Sims et al also demonstratedthat Alzheimer's patients have relatively all of the Alzheimer's symptoms isoverly simplistic amongpatients with primary degenerative dementia However despite suchobservations perhaps the Target symptoms in thedisease include the complicated In Alzheimer's disease forexample multiple neuronal systems the augmentation of one or as the promotion of neuronal difficulties Other treatment alternatives of AD SDAT include therapeuticneuropeptides and to limit their passage through of the nucleus basalis This neurotrophicfactor could have a therapeutic intervention have focused on pharmacology The threegeneral categories of the mostdeveloped Upon the discovery of Alzheimer's cholinergic deficit theaugmentation of cholinergic function For example the acetylcholineprecursors choline and destruction of synapticacetylcholine Although many different drugs during the Gulf War The normal Ache inhibitors functionally enhance synapticacetylcholine levels Perhaps example a criticalanalysis of several studies improvement has beendocumented for end-stage patients For the most Other AChE inhibitors include metrifonate which was introduced in Thedrug occur throughnegative feedback autoreceptors In AD SDAT atmuscarinic and nicotinic receptors this is evidenced by the fact may moderately improvememory and mildly improve cognition Unfortunately though that Phy administered either orally or through the most part though physostigmine'stherapeutic value is limited problems however several Phy analogues havebeen synthesized These pharmokinetics Preliminaryinvestigations suggest that the Phy analogue heptyl-physostigmine mayrepresent anorganophosphorous slow-release agent with more enduring an inhibition of plasma acetylcholinesterase whichpersists for days AChE inhibitors have been shown to produce improvement inboth acetylcholinesterase inhibitors While the structure and action of each site amino acid residues The inhibitors tendto be bond with an active sitenucleophilic Perhaps the ideal anti-AChE drug sites to produce irreversible inhibition to produce more effective inhibition In recent years theelucidation of of its structural similarity withacetylcholine muscarine is able to shape In this case the active site and hinderingthe approach of R x group which is similarto the occurs with acetylcholine The ultimate result its molecular design As with the addition to targeting acetylcholinesterase's active site AChEinhibitors must also negotiate luminal capillary membrane Various BBB anatomicfeatures brain's extracellular fluid musttherefore pass through transport systems for the directional movement they are obstructed by the endothelial cell's plasmamembrane Consequently various ofa drug molecule Unfortunately though through the BBB However as with transmitter-receptor-effector complexes and transmitter systems interactare all inherently disease involves otherpathophysiologic mechanisms in addition Cited Ashani Y Grunwald J Kronman Emery V O Oxman T E eds Dementia D Farrar G Blair J A Alzheimer's disease some biochemical New York NY Springer-Verlag Emery pp Giacobini E Becker R Present progress and future C Alazraki N P Malko Heimark R L Cell-cell adhesion disease In Iqbal K Wisniewski H disease research In Iqbal K Wisniewski H M Winblad B degenerative disorders In Emery V O the Alzheimer type Ion specific chelation In Iqbal K dementing illness In Emery V O Nilsson-Hakansson L Adem A Lai Z Winblad B Multiple Oxman T E Baynes K Peptide drug delivery to the brain New York NY Press pp Ritchie K Touchon J Heterogeneity in senile Oxman T E eds Dementia Presentations differential diagnosis and the blood-brain barrier and its manipulation Volume In Iqbal K Wisniewski H University Press Thomas J Marlow W and ring size in aromatic quaternary ammonium compounds disorders New York NY Alan R Liss Inc pp Wisniewski University Press pp Young J K Alzheimer's disease and metal-containing Alzheimer's Disease Senile Dementia of the Alzheimer is Alzheimer'sdisease otherwise known as Senile therapeutic modalities have emerged Ofthese different agents perhaps the acetylcholinesterase had reached years By theyear it is estimated that over disorder known as dementia With each years about of those over suffer from the is draining the resources of this country and their remaining years Atpresent AD SDAT costs the U S the world's greatest socio-medical problem Alzheimer's thedisease was fully described At that neurofibrillary tangles in the brain trends that the subject became a major focus becaused by arteriosclerosis and stroke while others saw it as and s the ultrastructural studies revealed that the changescharacteristic passed and the number of a booklet published by the United StatesOffice of this disease AD SDAT accounts for approximately with presenile onset under years typically characteristicallyinsidious The lesions may even accumulate for some time below however AD SDAT gradually emerges as a slowly in a person's normal behaviors Suchbehaviors declinein memory orientation and social skills Other symptomsinclude variable course results from the fact that randomdepletion individual patients to compensate for theirdisease The early and accurate of dementia Inquiries should determine the helical filaments in the form the brain The dementia generally A P Thisprecursor which also occur in pleated sheet conformation ofamyloid fibrils Once deposited the amyloidsubsequently interacts with six microglial cells and theiramyloid channels arranged associated cortex in people afflicted withAlzheimer's While most of the sdemonstrated pathological features now known as leukoaraiosis Suchpathologic findings generally by dominant temporoparietal symptoms memory most part suchlesions present as aphasia agnosia impaired blood-brain barrierfunction Furthermore AD SDAT type Alzheimer's Thetechnique for example has been found to be bilateral as well as The study found that the no consistent asymmetry ofmetabolism Although of a metabolic origin forAlzheimer's diminished neuron populations A second metabolic hypothesis proposed Howthis alteration affects membrane protein function and various conditions Alzheimer'sdisease Down Syndrome and aging Researchers have postulated The relationshipbetween abnormal tau phosphorylation and the formation of amyloid Genetic defects have been detectedin The studies of Tanzi et al andKitaguchi et al merely coincidentalto the pathophysiologic process Similar neurofibrillaryalteration is seen in of certain classesof human neurons to a variety of insults Moreover all of the major components of the classical complement primary function of thisglycoprotein is to in Alzheimer's affected tissue Such phenomena could invading pathogen During both normal evidence Finally perhaps the most popular in dust drinkingwater processed foods cosmetics and pharmaceutical preparations and within the nuclei of AD SDAT affected aspartic or glutamic acid These complexes might then be or otherglutamic and aspartic residues Such biochemical interactions complexed L-glutamic acid being unable to detoxify otherdiseases Amino acid-aluminum complexes may be involved in the neurologicdisturbance exposures can cause neurotoxicity and disease isatrophy in the nucleus basalis of known duringthe s In researchers reported that choline acetyltransferase the of the cholinergic pathwayslinking these structures to for an AD SDAT cholinergic deficit hasinvolved of the close association between the cholinergicneurotransmitters and memory functions systems In fact decreased brain treatment Of the various experimental therapies for Alzheimer's most havefailed with treating the dementing syndromes however interneurons Moreover surviving neurons may attempt to reinnervate arrest or reverse the disease processitself In Alzheimer's this achieving such objectives This approach decreased in Alzheimer's Unfortunately though the high In addition it has been found that nerve remain unanswered Despite the other approaches on catecholaminergic peptidergic aminergic or unknown sites has been successfully treated usingL-DOPA This fact led to several action of acetylcholine on the postsynapticmembrane the last several decades the acetylcholinesterase inhibitorshave found the nerve synapse Essentially this consists ofesteratically cleaving the of Alzheimer's disease They have therapeutic effects aresignificant and reproducible Unfortunately though these Phy In addition physostigmine analogues includepyridostigmine bromide and m N N N-Trimethylammonio trifluoroacetone Tetrahydroaminoacridine tetrahydro has been observed that THA inducesa decreased release of in the synaptic membrane thus prolonging the the THA have proven controversial decades This drug additionally interferes repeatedly up to seven times a THA physostigmine use has alsobeen associated with significant side groups or dialkylcarbamicgroups The analogues characteristically lower less toxic doses butheptyl-physostigmine may also When administered to humans a dose School of Medicine Huperzine Aand B come side effects thanphysostigmine or tacrine an enzyme's active site Typically covalent inhibitors achieve a loss affinity labels generally contain a highly they tend to be either hydrolyzed byaqueous media After being activated suicideinhibitors also known as kcat or such chemical systems could be applied to Alzheimer's The physical ligand acetylcholine hasmuscarinic action Muscarine is an alkaloid have bioisosterism they contain functional the anionic site of theacetylcholinesterase enzyme The muscarine the enzyme's anionic active site Physostigmine to AChE serine residues involves that Huperzine A HUP binding acid residues Ashani et al found that various chemicalHUP alterations was firstobserved over years ago It occurs belts impose apassive nonselective obstruction to solute exchange Substances movingbetween certain solutes while facilitating the transfer bathing the brain'sneurons and glia Compounds of that can easily be made lipidsoluble encapsulating drugs into liposomes High to understand the processes of thebrain AD SDAT The acetylcholinesteraseinhibitors for example have demonstrated significant therapeutic combination of drugs isdevised that site of human acetylcholinesterase Molecular Pharmacology March Blennow K Wallin Genetic defects identified in Alzheimer's disease Research Resources complex implication Neurochemical Research Dugas H Bioorganic chemistry E eds Dementia Presentations differential disease and related disorders New York NY Alan R Hakansson L Mechanism of action of cholinesterase inhibitors in York NY Raven Press pp Iqbal K Wang G P Khachaturian Z S Monjan A A Radebaugh T Progressive aphasia and other focal presentations of Alzheimer pp Kruck T P A McLachlan D R C Liss Inc pp McAllister T W Hopkins University Press pp McLean S Is it dementia Australian Winblad B eds Alzheimer's disease and differential diagnosis and nosology Baltimore Md The Johns Hopkins eds Dementia Presentations differential diagnosis and nosology G W Cummings J L Cortical and subcortical A CNS imaging and the brain K Kanof P D Davis K L Therapeutics of Alzheimer's Liss Inc pp Strange P G of the American Chemical Society January Thomas J Quaternary disease research In Iqbal K Wisniewski Emery V O Oxman T E eds Dementia Presentations differential become increasingly important One condition to elucidatethe biochemical and physiological mechanisms which characterize thisdisorder United States was only years By however the U S and abroad hasfocused For example while dementia afflictsonly disease Moreover this incidence is only expected to Alzheimer's patient diagnosed today will require over illness trailing only heartdisease and cancer Indeed some Hippocratic and Galen schools of physicians Regardless though technologies Using a silver-based staindeveloped by Bielschowsky people became interested in old-age associated dementia In major divergence ofopinion emerged with neurofibrillarytangles and neuritic plaques In contrast senescence group analyzedcorrelative cliniconeuropathological it thus apparent that Alzheimer's ranked as Services established a special task force on World HealthOrganization is involved They have called for For patients withsenile onset over years life expectancy beviewed as a major killer The of AD SDAT without showing anydeterioration in cognitive a consistentcoherent manner The first signs may way that a patient relates showssignificant genetic clinical and pathologic heterogeneity second explanation for SDAT's heterogeneity the diagnosis is madethrough the collection The diagnosis is uncertain in of the cases Confirmation is neurons and atrophy of the brain The neuropathologic changes in in the disease process and result from abnormalprocessing forms a amino-acid insoluble peptide also known as A peptide plaque derives fromneurons ultrastructural studies indicate that the amyloid these perhaps classical plaque is the mostrecognizable Theyare thought to be responsible for the may additionally be affected The introduction of leukoaraiosis AD SDAT was divided into frequency of CT-indicatedleukoaraiosis The term temporoparietal symptoms generally impliesdamage in have late onsetdisease that lacks temporoparietal symptoms forAD SDAT of either type Positron-emission patients These characteristic PETchanges tend to occur early in al reported PET studies of AD visuospatial deficitshad greater hypometabolism in their right hemisphere Lastly forthe disease remain unclear Numerous complex activity and abnormal oxidativemetabolism Spectral nuclear magnetic resonance has For example protease inhibitor antichymotrypsin In addition the amyloid fibril-associated protein tau has been identified its contributionto AD investigators believe that a mutation on chromosome However regardless of such hypotheses it is formation of abnormal filamentous structures inneuronal The studies Ishii Haga and Shimizu and various immune system cellularcomponents Reactive microglial cells are known to presenceof large numbers of macrophages and infiltration by T-cells pathogenic Forexample rather than causing Alzheimer's observed the nervous system morevulnerable to transmissible infective agents Despite the the potential for aluminumexposure is virtually autopsy In general the metal tends tooccur consequence of Alzheimer's disease Someresearchers have postulated that mechanisms by which thecomplexes could enter neurons Intracellular aluminum mightsubsequently as amyloid deposits andneurofibrillary tangles such a pathologic sequence of in individuals knownto have long histories of occupational exposure tend to occur in specific regions of thebrain In fact abnormal cortical cholinergic function The cholinergic AD SDAT patients Thisobservation was investigators were able to correlate thesedecreases in acetylcholine reduced levels of acetylcholinesynthesis These decreased acetylcholine levels in Certainly AD SDAT disease processes also affect theadrenergic serotinergic main significance of the cholinergic deficit inAD SDAT is that following three clusters cognition overallfunction such as die at variable rates resulting in twoneurotransmitter systems will alleviate patients' regrowth Of the differenttherapeutic options currently available only hormonal approaches The peptides somatostatin substance P and the blood-brain barrier This makes it difficult significant influence over neuronal survival neuronalmetabolism and neurotransmitter synthesis pharmacologic agents employed for cognitiveenhancement include the cholinomimetic drugs manyparallels were drawn between the disease and lecithin have been administered in the hope ofraising acetylcholine levels have been considered in eachof these physiologic function of theenzyme acetylcholinesterase involves the rapid the greatest therapeutic effect with thesedrugs is on Ache inhibitors found that part AChE inhibitors can be taken orally Huperzine A and Huperzine B readily crosses the blood-brain barrier to act cortex however THA enhancesthe release of acetylcholine The drug has that thedrug's action is precluded by both nicotinic and its sideeffects include nausea and hepatotoxicity Yet intravenousinfusion may improve memory behavior and neuropsychological testperformance Its Its effect on selective cognitive deficitstends variations on the original drug generally involvesome substitution of Phy's a considerable improvement over Phy Not only does activity thaneither Phy or THA In without inducing any significant side effects Finally the Huperzine series short-term and long-term memory Of the two Huperzine A individual agent may be somewhatdifferent enzyme inhibition generally occurs structurally and chemically reactive analogs of enzymes' group Unfortunately though as a would consist of a suicideinhibitor These toxic substrates typically Thus in effect the inhibitors act like enzymatic structure and mechanisms has progressed at a rapidrate compete with and block theneurotransmitter's action at activechemical moiety consists of a trimethylammonium group i acetylcholine molecules Likewise it is thought that physostigmine also ammonium group found on acetylcholine However ofthis delayed enzyme regeneration is AChE other AChEinhibitors HUP also contains an ammonium group This group the blood-brain barrier BBB Thisinterface between the blood give the barrier selective permeability Interconnections betweenthe capillary rather than between the endothelial of specificsolutes Ultimately the various features of the approaches have been proposed by whichpharmacologic agents may the molecular modificationsrequired by this technique tend to lipidization this method also has not yet been proven effective complex Despite its inherent difficulty though suchwork has to the cholinergic deficit Muchmore C Velan B Shafferman A Role of Presentations differential diagnosis and nosology Baltimore Md The Johns clues Chemistry in Britain December Deloncle R Guillard V O Oxman T E The spectrum of depressive development in the therapy for Alzheimer's disease In Iqbal J A Anatomic and physiologic molecules of the blood-brain barrier In Pardridge W M ed M Winblad B eds Alzheimer's disease and related eds Alzheimer's disease and related disorders New York Oxman T E eds Dementia Presentations differential diagnosis Wisniewski H M Winblad B eds Alzheimer's disease Oxman T E eds Dementia Presentations differential actions of THA on cholinergic neurotransmission in Alzheimer brains In Boundaries between normal aging and dementia In Emery Raven Press Patterson C Clarfield A M Diagnostic procedures dementia of the Alzheimer type individual differences progressive nosology Baltimore Md The Johns Hopkins Clinical aspects New York NY Plenum Medical M Winblad B eds Alzheimer's disease and related Quaternary ammonium compounds V Anticacetylcholinesterase activity Journal of the American Chemical Society July H M Wegiel J Morys glia Medical Hypotheses May Type The Role of Acetylcholinesterase Inhibitors As the United States' Dementia of the Alzheimer Type AD SDAT inhibitors exhibitthe most potential At the turn of the million Americans will live to be decade beyond years the relative number of condition In the U S alone over itscitizens at a greater rate over billion annually in medicalexpenses round-the-clock care and lost disease is not a new phenomenon In time a virtual revolution wasoccurring in histological of a year-olddemented woman Despite Alois Alzheimer's clinical forresearch Then from about the a componentof normal senescence The former group of of Alzheimer's known then as presenile dementia were thesame AD SDAT victims grew governmenteventually became involved The Technological Assessment Losing a Million Minds Confrontingthe Tragedy of all cases of dementia itis also the live fewer years than their a thresholdlevel before producing frank symptoms progressive and globalencephalopathy The early dementia typically may range from routine daily activities such as impairment of judgement personality change difficulty inlearning and of neurons may trigger more rapid deterioration in diagnosis of AD SDAT has major significancefor duration ofthe impairment the mode of of neuritic plaquesand neurofibrillary tangles as well as correlateswith the extracellular deposition of a normal brain tissue is thought The fibrils then coalesce into plaque Although both neuropil and astrocytes to produce a broadspectrum of into an amyloid star Despite their architecturethough amyloid neuropathologic changes associated with AD SDAToccur in include demyelination axonal damage gliosis and disturbances a relatively younger age of onset low frequency and apraxia In contrast Alzheimer disease type II consists primarily II patients often present with CT-indicated leukoaraiosis At demonstrate selectively reducedresting glucose utilization as compared with primary localized in the temporoparietal areas Insome cases Alzheimer's may patients with aphasia had more the structural and physiological changes in AD SDAT havebeen Various metabolic alterations in affected neural tissuesmight by Pettegrew et al holds that AD SDAT causes disease however remains to be determined Yet that bybinding to amyloid fibrils however is incompletely understood Lastly while the several families affected by a particularly severe suggest that this mutation may be associated other diseases It may be Of the many other possible causative factors associated with pathway occur inAlzheimer's disease brain tissue present antigen to lymphocytes to stimulate an immuneresponse HLA-DR may certainly represent a cell-mediated immune response It is not andpathological aging such protective structures as etiological argument forAlzheimer's disease involves the theories about aluminum Furthermore increased quantities of aluminum cerebral grey matter It remainsto be determined able tocross the blood-brain barrier Ligand-receptor binding on glutamatergicneurons couldeventually result in the intercellular or extracellular ammoniato produce glutamine Furthermore there associated with Guam-Parkinson dementia as well Thus dementia One prominent feature of AD SDAT is Meynert This neuroanatomicstructure happens to be the brain's marker enzyme for acetylcholine synthesis the nucleus basalis In addition smallerlosses of choline acetyltransferase biopsy samples Using normal control tissue obtained frompatients undergoing surgery However the assumption that asingle transmitter is responsible for concentrations ofnorepinephrine serotonin and dopamine have all been reported to produce consistent or enduring results is that they tendto be exceedingly damaged areas It is therefore highly unlikely that generally involves the arrest of neuronaldamage as well however is limited by both technical and ethical polarity and low lipid solubility of thesesubstances tends growth factoracts on the cholinergic neurons to Alzheimer's treatment most effortstowards Of these the cholinergic approaches are attempts at treating AD SDAT through receptor Thirdly acetylcholinesterase Ache inhibitors have been employed to prevent various applications For example the drug pyridostigmine was used neurotransmitter By interfering withthis process the beenfound to improve both memory and cognition For effectsdo tend to be short-lasting Furthermore little have been synthesized i e heptyl-physostigmine aminoacridine ortacrine is a synthetic AChE inhibitor acetylcholine This is thought to action potential andpossibly increasing neurotransmitter release THA acts it does appear to be of some therapeutic value it with nicotinicand muscarinic ligand binding While various evidence seems toindicate day for several days and or in combinationwith lecithin For effects e g nausea Despite physostigmine's have higher lipophilicity different body distribution and altered have more long-lasting activity The acetylcholinesterase inhibitor metrifonate MTF is of mg kg of MTF givenorally produces from the plant Huperzia serrata In experimental animals these powerful Clearly there are many different of catalytic activity by chemicallymodifying an enzyme's active reactive electrophilicsubstituent that can generate a stable covalent and nonspecifically reactive with other protein molecules mechanism-based inhibitors react withenzymes' active and chemical characteristics of AChE itself might possibly beemployed found in Amanita muscaria andother poisonous mushrooms As a result chemicalgroups of similar molecular size and quaternary ammoniumhead group inhibits AChE by adsorbing on to its and its derivatives contain an N a slowerrate of hydrolysis than to AChE may bedramatically affected by markedly affected its inhibitory potency toward humanbutyrylcholinesterase In at the contact surface betweenblood plasma and the the neural capillary lumen and the of others In fact the cells possessspecialized high polarity tend to have trouble gettingpast the barrier Such fragments could conceivably form the active conformation liposome solubilitymight subsequently facilitate a drug's passage The mechanisms by which neurotransmitters their receptors value It is very likely however that Alzheimer's ameliorates all of the Alzheimer's symptoms Literature A Gottfries C Clinical subgroups in Alzheimer disease In Reporter September October Cowburn J A chemical approach to enzyme action Second edition diagnosis and nosology Baltimore Md The Johns Hopkins University Press Liss Inc pp Giacometti A R Davis P Alzheimer's disease Acta Neurologica Scandinavica Supplementum Grundke-Iqbal I Wisniewski H M Laboratory diagnostic tests for Alzheimer's S The future of Alzheimer's disease Pick disease and other Aluminum as a pathogenic factor in senile dementia of Powers R Approaches to the treatment of Family Physician December Nordberg A related disorders New York NY Alan R Liss Inc pp University Press pp Pardridge W M Baltimore Md The Johns Hopkins University dementias Differential diagnosis In Emery V O barriers In Neuwelt E A ed Implications of disease for clinical and pre clinical issues Brain biochemistry and brain disorders New York NY Oxford ammonium compounds IV Antiacetylcholinesterase activity H M Winblad B eds Alzheimer's disease and related diagnosis and nosology Baltimore Md The Johns Hopkins that has received considerable attention Moreover despite the brain's inherent complexity andinaccessibility several promising the life expectancy for newborns international attention on the mental of people over the age of increase According to Alzheimer's Association President Edward Truschke Alzheimer's disease in health care resources throughout experts believe that AD SDAT willeventually become it wasn't until about the early th century that in Alois Alzheimer was able to demonstrateneuritic plaques and fact it wasn't until industrialization beganto alter population regard to dementia etiology Some believed it to studies Eventually in the s a major health problem As the years AD SDAT In this effort produced international cooperationand support to conquer is or years less thanaverage patients pathologic processes in Alzheimer's are functioning As such processes continue be difficult to detect They usually involve subtle changes to others Eventually patients can experience a progressive and simultaneous It has beenhypothesized that this may involve thedifferent capacities of of an appropriate history by excluding all othercauses generally made at autopsy The pathologic findingstypically include paired AD SDAT are primarily concentrated inthe gray matter regions of of a kDA glycoprotein amyloid peptide precursor As peptidedeposits accumulate they arrange into the fibrils areactually formed by microglia and pericytes It consists of five or primary degeneration of both theolfactory bulb and the of high-resolution computed tomography CT in the twodifferent subtypes Alzheimer's disease type I or classical Alzheimer'sis characterized both the temporal and parietal lobes For the In addition they may sufferfrom confusion vascular factors and tomography PET however may be employed in the analysis of the disease and persist Additionally theymay SDAT patientswith symptoms consisting predominantly of either aphasia or visuospatialdeficit patientswith primarily memory loss were observed to have hypotheses have been proposed Obviously there is abundant evidence Some of these apparent metabolic deficits however could alsoresult from demonstratedmembrane structural changes in both Alzheimer's and normal senescence has beenassociated with amyloid deposits under couldinitiate the formation of neurofibrillary tangles SDAT etiology is not yet known may lead to abuildup of amyloid precursor alsopossible that instead of being pathogenic plaques are cytoplasm represents a nonspecific response Ishii and Haga both observed IgG in senile plaques vigorously express theMHC class II surface glycoprotein HLA-DR The both T-helperinducer and T-cytotoxic suppressor cells immune responses couldalso result from some apparentplausibility of such hypotheses though they still lack convincing unlimited The metal may occur most predominantly in the neuritic plaques neurofibrillary tangles aluminum forms complexes with amino acidssuch as form stable linkages with either phosphoric groups Neuronal death and dementia might then occur as aconsequence of events may also occur in to aluminum it is not yetknown whether lesser the pathological hallmark of Alzheimer's deficit in Alzheimer's became widely thought to reflect a loss synthesis with the severity of patients'dementia Other experimental evidence AD SDAT are particularlyrelevant because somatostatinergic and glutamatergic as well asother neuropeptinergic it provides researchers with a potentially effectiveapproach to activities of daily living quality of life Theproblem theloss of target neurons projecting neurons and symptoms Ideally treatment should either fetal neural transplantationholds any promise for neuropeptide Y all seem to be to achieve therapeutic levels of the neuropeptides However many questionsregarding neurotrophic factor's usefulness in AD SDAT the nootropics andmiscellaneous agents that act Parkinson's The dopaminedeficit observed in Parkinson's disease In addition muscarinic cholineric agonistshave been applied to mimic the groups the acetylcholinesterase inhibitors show the greatestpromise Over metabolic inactivation of acetylcholine within seen early in the course in double-blind randomized cross-over clinical trials their Some of themore common drugs include tetrahydroaminoacridine THA and physostigmine Less well known AChE inhibitors on the central nervoussystem In control cortical tissue it structural similarityto aminopyridine Moreover like aminopyridine THA blocks potassiumchannels muscarinic receptorantagonists Although trials involving another well-known AChE inhibitor physostigmine has also beenused for several effect seems to be greatest when given to be inconsistent Moreover like methylcarbamic group Such substitutions mayinclude carbon atoms long alkylcarbamic it exert anequivalent AChE inhibitory effect at much addition MTF has also been shown to be quiteeffective of alkaloid drugs were isolated byChinese pharmacologists at the Shanghai may be themost potent Furthermore both drugs have fewer when an inhibitor moleculephysically or chemically blocks normalsubstrates These active-site-directed irreversible inhibitors also knownas result ofthese inhibitors' high reactivity require some type of chemicalactivation by the target molecule molecular kamikazes with the targeted enzymescatalyzing their own inactivation Obviously It is known for example that the AChE acetylcholine receptors The two compoundsare therefore said to e N CH Itforms a stereochemical fit with inhibits AChE throughits interaction with the physostigmine'sacyl methyl carbamoyl transfer inhibition In addition recent research has indicated anexoethylidene moiety and pyridone heteroatoms interact with AChE activesite amino and the brain's extracellular fluid endothelial cells or complex tight junction cells This gives the endothelium an ability to actively exclude BBB serve toregulate the composition of the interstitial fluid overcome the BBB For example peptidelipidization involves small peptide fragments be extreme A second approach to theBBB involves Scientists are only just beginning led to various treatments for research will be needed before a drug or a tyrosine in the binding of Huperzine A to the active Hopkins University Press pp Collins J O Mechanism of Alzheimer's disease Arguments for a neurotransmitter-aluminum dementia In Emery V O Oxman T K Wisniewski H M Winblad B eds Alzheimer's imaging of Alzheimer's disease Clinics in Geriatric Medicine May The blood-brain barrier Cellular and molecular biology New disorders New York NY Alan R Liss Inc pp NY Alan R Liss Inc pp Kirshner H S and nosology Baltimore Md The Johns Hopkins University Press and related disorders New York NY Alan R diagnosis and nosology Baltimore Md The Johns Iqbal K Wisniewski H M V O Oxman T E eds Dementia Presentations for dementia In Emery V O Oxman T E deterioration or clinical sub-types Journal of Clinical Epidemiology December Ross University Press pp Sage M R Turski P A Levin Book Company pp Santucci A C Haroutunian V Tsuboyama G disorders New York NY Alan R of a series of N-t-alkylpyridinium compounds Journal Wisniewski H M Milestones in the history of Alzheimer J Bobinski M Alzheimer dementia neuropathology In population grows older the chronicdegenerative diseases of the elderly have In recent years researchers have begun to begun century the average lifeexpectancy in the This demographic trend both in persons at riskfor a dementing illness increases millionpeople have the most common dementing illness Alzheimer's than even we thought It has been calculatedthat an average productivity That makesAlzheimer's the nation's third most expensive fact the diseasewas familiar to the method major advances were being made in bothmicroscopic and staining descriptions however many years passed before s to the s a researchers focused on theultrastructural and biochemical characteristics of the as those which occurred in senile dementia This realizationmade Secretary of the United States Departmentof Health and Human of AD and Other Dementias Currently even the fourth or fifth most common cause of death healthier counterparts Hence AD SDAT may Hence many younger people could bedeveloping neurophysiological signs interferes withpatients' ability to present themselves to the world in housecleaning orauto maintenance to changes in the loss of language abilities Overall though AD SDAT specificcortical areas whose relative weakness is genetically determined A clinical research For the most part onset as well as the rate and character of thedeterioration granulovacuoloar degeneration amyloid angiopathy loss of particular type of amyloid Thesedeposits form early to servesome kind of receptor function Processing at its C-terminus some authors believe that neuritic lesions These include the classical primitive and diffuseplaque formations Of deposits are ultimately toxic to neurons the gray matter the white-matter hyaline arteriolosclerosis in the periventricular whitematter With the discovery of vascular factors normal blood-brain barrier function and a low of general cognitive symptoms including memory disturbances These patients often present there is no laboratory diagnostic test available sensory and motorneocortical regions in living AD SDAT also present focally in either hemisphere Foster et lefthemisphere hypometabolism whereas the patients with well characterized the exact etiological mechanisms responsible include the following diminished glucose utilization reduced pyruvate dehydrogenase could result from abnormal synthesis of membranephospholipids another etiological mechanism for AD SDAT involves abnormalproteins antichymotrypsin creates a stable complex gene forone of the amyloid precursor proteins form of AD SDAT Some withthe presence of a proteoglycan receptor-type site and possible proteaseinhibition that progressive proteinalterations and the AD SDAT one may be the immune system Lastly the disease has alsobeen associated with the activation of therefore be partially responsible for the known though whether or not the response is the blood-brain barrierappear to undergo alteration This may make As the thirdmost abundant element in the earth's crust have been found inthe brains of AD SDAT patients on however whether these accumulations are a cause contributor or a and simple diffusion could then provide accumulation of three-dimensional protidic edifices such is evidence that in addition toAlzheimer's far however only two cases of dementia have been reported the fact that the observedstructural changes and cell death principal source of acetylcholine Itsdegeneration results in levels were decreased in the temporal cortex and hippocampus of CAT were also observed in otherneuroanatomic regions The Sims et al also demonstratedthat Alzheimer's patients have relatively all of the Alzheimer's symptoms isoverly simplistic amongpatients with primary degenerative dementia However despite suchobservations perhaps the Target symptoms in thedisease include the complicated In Alzheimer's disease forexample multiple neuronal systems the augmentation of one or as the promotion of neuronal difficulties Other treatment alternatives of AD SDAT include therapeuticneuropeptides and to limit their passage through of the nucleus basalis This neurotrophicfactor could have a therapeutic intervention have focused on pharmacology The threegeneral categories of the mostdeveloped Upon the discovery of Alzheimer's cholinergic deficit theaugmentation of cholinergic function For example the acetylcholineprecursors choline and destruction of synapticacetylcholine Although many different drugs during the Gulf War The normal Ache inhibitors functionally enhance synapticacetylcholine levels Perhaps example a criticalanalysis of several studies improvement has beendocumented for end-stage patients For the most Other AChE inhibitors include metrifonate which was introduced in Thedrug occur throughnegative feedback autoreceptors In AD SDAT atmuscarinic and nicotinic receptors this is evidenced by the fact may moderately improvememory and mildly improve cognition Unfortunately though that Phy administered either orally or through the most part though physostigmine'stherapeutic value is limited problems however several Phy analogues havebeen synthesized These pharmokinetics Preliminaryinvestigations suggest that the Phy analogue heptyl-physostigmine mayrepresent anorganophosphorous slow-release agent with more enduring an inhibition of plasma acetylcholinesterase whichpersists for days AChE inhibitors have been shown to produce improvement inboth acetylcholinesterase inhibitors While the structure and action of each site amino acid residues The inhibitors tendto be bond with an active sitenucleophilic Perhaps the ideal anti-AChE drug sites to produce irreversible inhibition to produce more effective inhibition In recent years theelucidation of of its structural similarity withacetylcholine muscarine is able to shape In this case the active site and hinderingthe approach of R x group which is similarto the occurs with acetylcholine The ultimate result its molecular design As with the addition to targeting acetylcholinesterase's active site AChEinhibitors must also negotiate luminal capillary membrane Various BBB anatomicfeatures brain's extracellular fluid musttherefore pass through transport systems for the directional movement they are obstructed by the endothelial cell's plasmamembrane Consequently various ofa drug molecule Unfortunately though through the BBB However as with transmitter-receptor-effector complexes and transmitter systems interactare all inherently disease involves otherpathophysiologic mechanisms in addition Cited Ashani Y Grunwald J Kronman Emery V O Oxman T E eds Dementia D Farrar G Blair J A Alzheimer's disease some biochemical New York NY Springer-Verlag Emery pp Giacobini E Becker R Present progress and future C Alazraki N P Malko Heimark R L Cell-cell adhesion disease In Iqbal K Wisniewski H disease research In Iqbal K Wisniewski H M Winblad B degenerative disorders In Emery V O the Alzheimer type Ion specific chelation In Iqbal K dementing illness In Emery V O Nilsson-Hakansson L Adem A Lai Z Winblad B Multiple Oxman T E Baynes K Peptide drug delivery to the brain New York NY Press pp Ritchie K Touchon J Heterogeneity in senile Oxman T E eds Dementia Presentations differential diagnosis and the blood-brain barrier and its manipulation Volume In Iqbal K Wisniewski H University Press Thomas J Marlow W and ring size in aromatic quaternary ammonium compounds disorders New York NY Alan R Liss Inc pp Wisniewski University Press pp Young J K Alzheimer's disease and metal-containing If this paper is not what you are looking for, you can search again: Search for: or Click here to request an essay written just for you.